These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
757 related articles for article (PubMed ID: 23934958)
1. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome. Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958 [TBL] [Abstract][Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Liu ID; Willis NS; Craig JC; Hodson EM Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142 [TBL] [Abstract][Full Text] [Related]
3. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome. Wang XB; Dai EL; Xue GZ; Ma RL Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831 [TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome. Feng M; Yuan W; Zhang R; Fu P; Wu T Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006335. PubMed ID: 23740567 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy. Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952 [TBL] [Abstract][Full Text] [Related]
10. Interventions for focal segmental glomerulosclerosis in adults. Hodson EM; Sinha A; Cooper TE Cochrane Database Syst Rev; 2022 Feb; 2(2):CD003233. PubMed ID: 35224732 [TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine for oesophageal cancer. Chen X; Deng L; Jiang X; Wu T Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004520. PubMed ID: 26799001 [TBL] [Abstract][Full Text] [Related]
12. Herbal medicines for viral myocarditis. Liu ZL; Liu ZJ; Liu JP; Kwong JS Cochrane Database Syst Rev; 2013 Aug; (8):CD003711. PubMed ID: 23986406 [TBL] [Abstract][Full Text] [Related]
13. Oral traditional Chinese medication for adhesive small bowel obstruction. Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734 [TBL] [Abstract][Full Text] [Related]
18. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome. Yuan W; Wang J; Wu T Cochrane Database Syst Rev; 2008 Apr; (2):CD006335. PubMed ID: 18425948 [TBL] [Abstract][Full Text] [Related]
19. Herbal medicines for viral myocarditis. Liu ZL; Liu ZJ; Liu JP; Kwong JS Cochrane Database Syst Rev; 2012 Nov; 11():CD003711. PubMed ID: 23152220 [TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering agents for nephrotic syndrome. Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]